Philips highlights latest sleep innovations enabling more efficient care from diagnosis to compliance at SLEEP 2017

AMSTERDAM and BOSTON, June 5, 2017 /PRNewswire/ -- At SLEEP 2017 taking place in Boston, Mass. from June 3-7, Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, will showcase its expanding portfolio of cutting-edge sleep solutions, designed to offer more effective and efficient care from the time of diagnosis through treatment and adherence to therapy. 

"These emerging solutions for people with sleep disorders provide hope for those who want to live healthier and more meaningful lives," said Dr. Teofilo Lee-Chiong, Chief Medical Liaison at Philips. "At Philips, we understand that encouraging healthy life choices is as important as treating unhealthy disorders. We are committed to creating technology and services that facilitate delivery of care, enhance patient experience, improve disease outcomes and reduce healthcare costs."

In addition to the solutions showcased at the conference, David Plummer, former Olympic gold medalist swimmer who suffers from sleep apnea, will speak at a Philips-hosted dinner during SLEEP 2017, discussing his personal journey with sleep apnea and how receiving an accurate diagnosis and finding the right therapy helped him to use therapy as prescribed and ultimately helping him to improve his performance in the water and, more importantly, as a father.

"Traveling was a big part of my life when I was training and competing for the 2015 World Cup Circuit, and continues to be play a large role as I still travel frequently with my family," said Plummer. "I recently started using Philips DreamStation Go, which has really made traveling easy for me thanks to how small and easy-to-pack it is. It's the exact same therapy as the DreamStation that changed my life, so I'm not missing out on that therapy when I'm on the road or in the air."

Show attendees will have the opportunity to view the latest innovations from Philips in sleep and respiratory care that aim to:

• Streamline the continuum of care from diagnosis onward: Launched in May, Philips Portable Device Manager allows sleep labs to track all of their portable devices within Sleepware G3 and track progress through the home sleep test cycle.  Coming in August and shown for the first time at APSS, Sleepware G3 Bedside Assistant will integrate with Alice in-lab beds, displaying raw signals, video and lab titration settings, enabling mobile bedside management for lab techs.
• Provide patients with more options: DreamStation Go, Philips newest and smallest positive airway pressure (PAP) device, is designed to simplify travel for patients living with obstructive sleep apnea. At half the size of Philips' previous generation devices, DreamStation Go delivers the same clinically-proven performance and comfort as for reliable, convenient therapy on-the-go. Philips will also introduce a new addition to its award-winning line of innovative DreamWear sleep therapy masks. DreamWear Gel Pillows features the same comfort and freedom of movement as the original, but now offers an additional choice in cushion type that can be easily changed out within the same open faced mask frame.
• Help improve patient engagement and adherence: Now offering automated long-term compliance monitoring, Care Orchestrator is Philips next generation connected health application that connects homecare providers, physicians, and payers with patients across the entire health continuum, enabling remote monitoring and management. Patient Adherence Management Service (PAMS) is Philips telehealth service that uses sleep coaches to personally support patients new to PAP therapy, 79.5% of whom go on to meet the 90-day CMS compliance guidelines^[1]. DreamMapper, a mobile and web-based application shown to improve adherence to PAP therapy by helping hundreds of thousands of patients engage directly with their therapy will also be showcased.

With 10 years and more than 2.5 billion nights of cloud-based sleep therapy data from more than five million connected devices, Philips is continuously leveraging our growing connected sleep landscape to innovate new and impactful services like those showcased at SLEEP 2017. Philips aims to become a total sleep company by 2020, complementing its core sleep apnea solutions with expanded range of solutions and services to make a better night's sleep accessible to anyone.

To see the diversified portfolio of sleep products and presentations from Philips' experts, visit the Philips Product Pavilion at Booth #1408 at the Hynes Convention Center in Boston.  For updates on Philips' presence at SLEEP 2017, visit http://philips.to/1sdjDqI and for more information on Philips' advanced solutions for sleep and respiratory care, follow @PhilipsResp or visit www.sleepapnea.com.

For further information, please contact:
Meredith Amoroso
Philips Sleep and Respiratory Care
Mobile: +1 724-584-8991
E-mail: [email protected] 

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2016 sales of EUR 17.4 billion and employs approximately 70,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

[1] Retrospective study using 2014-2016 EncoreAnywhere data comparing 90 day compliance rate between 12 Home Care Providers using PAMS for at least six months compared to all other DMEs with at least 1,000 PAP setups using the CMS Compliance definition – minimum 4 hours of use over 70% of nights during a consecutive 30-day period within first 90 days of use.

SOURCE Royal Philips

Related Links

http://www.usa.philips.com